KEGG: neu:NE2049
STRING: 228410.NE2049
The rplA gene in Nitrosomonas europaea encodes the 50S ribosomal protein L1, which is a crucial component of the bacterial ribosome. This protein participates in the assembly of the large ribosomal subunit and is involved in protein synthesis. In the Nitrosomonas europaea genome, which consists of a single circular chromosome of 2,812,094 bp, rplA is one of the 2,460 protein-encoding genes identified .
Research has demonstrated that mutations in rplA result in marked attenuation of virulence in certain bacterial species, with an LD50 of >10³ CFU . While N. europaea is not pathogenic, the conservation of rplA across bacterial species suggests its fundamental importance for bacterial growth and metabolism.
The comparison of ribosomal proteins across different bacterial species can provide insights into evolutionary relationships. The table below compares key characteristics of rplA in different bacterial species:
For expressing recombinant N. europaea rplA, several expression systems can be considered, with Escherichia coli being the most commonly used for bacterial proteins. Based on recombinant protein expression studies, the following systems have proven effective:
E. coli expression system: Most suitable for bacterial ribosomal proteins due to similar codon usage and post-translational modifications. Typically, strains like BL21(DE3) or Rosetta are used with pET vector systems to control expression levels .
Yeast expression systems: These can be employed when proper folding is challenging in prokaryotic systems. Both Pichia pastoris and Saccharomyces cerevisiae have been used for expressing bacterial proteins .
Baculovirus/insect cell systems: These may be considered for complex bacterial proteins that require specific folding environments .
The methodological approach should include:
Codon optimization for the selected expression system
Inclusion of appropriate affinity tags (His-tag or GST-tag) for purification
Design of suitable promoters (IPTG-inducible for E. coli)
Optimization of growth conditions using Design of Experiments (DoE) approach
Optimization of expression conditions is crucial for obtaining soluble recombinant N. europaea rplA. Based on similar recombinant protein expression studies, the following conditions are recommended:
Growth and induction parameters:
Cell density at induction: OD600 of 0.8
IPTG concentration: 0.1 mM
Post-induction temperature: 25°C
Induction time: 4 hours
Medium composition: 5 g/L yeast extract, 5 g/L tryptone, 10 g/L NaCl, 1 g/L glucose
These conditions have been validated to produce high levels (approximately 250 mg/L) of soluble recombinant protein with appropriate functional characteristics . For N. europaea rplA specifically, lower temperatures during induction (16-25°C) are likely beneficial to enhance proper folding.
Experimental design methodology is highly recommended for optimization, as demonstrated in recombinant protein expression studies where a 2^8-4 factorial design was applied to evaluate eight variables related to medium composition and induction conditions .
Design of Experiments (DoE) is a powerful approach for optimizing recombinant protein expression, particularly for challenging proteins like rplA from N. europaea. A systematic DoE methodology includes:
Factor Identification: For N. europaea rplA expression, critical factors include:
Temperature (16-37°C)
IPTG concentration (0.1-1.0 mM)
Cell density at induction (OD600 0.4-1.0)
Post-induction time (2-16 hours)
Media composition (minimal vs. rich)
pH (6.8-8.0)
Oxygen levels
Additives (glycerol, glucose, etc.)
Experimental Design: A fractional factorial design (e.g., 2^8-4) can be employed to screen these factors with a minimal number of experiments .
Response Measurement: Key responses include:
Protein yield (mg/L)
Solubility percentage
Functional activity (if applicable)
Statistical Analysis: Analysis of variance (ANOVA) to determine significant factors and interactions.
Optimization: Response surface methodology (RSM) to fine-tune the significant factors identified in screening.
This approach has been successfully used for other recombinant proteins, resulting in up to 75% homogeneity and retention of functional characteristics .
The structural characteristics of N. europaea rplA that contribute to ribosome assembly can be studied using various methodological approaches:
Sequence Analysis and Structural Prediction:
Comparative sequence analysis with other bacterial L1 proteins
Secondary structure prediction using bioinformatic tools
Identification of RNA-binding domains and protein-protein interaction sites
Experimental Structure Determination:
X-ray crystallography of purified recombinant rplA
Cryo-electron microscopy of ribosomal assemblies containing rplA
NMR spectroscopy for dynamic regions
Functional Characterization:
RNA binding assays to examine interaction with 23S rRNA
Ribosome assembly assays in vitro
Site-directed mutagenesis of conserved residues
The L1 protein typically contains an N-terminal domain involved in binding to 23S rRNA and a C-terminal domain involved in interactions with other ribosomal proteins. Specific conserved residues are crucial for these interactions and can be identified through comparative genomic analysis.
The expression of native rplA in N. europaea is influenced by various growth conditions, which can provide insights for optimizing recombinant production. Studies on N. europaea transcriptomics reveal:
Oxygen Limitation Effects:
Transcriptomic studies of N. europaea under oxygen-limited conditions showed differential expression of various genes . While specific data on rplA expression is limited, ribosomal proteins generally show altered expression under stress conditions.
Ammonia Availability Impact:
As an ammonia-oxidizing bacterium, N. europaea's metabolism is significantly affected by ammonia availability. Under ammonia-limited conditions, N. europaea consumed NH₃ at a rate (qNH₃) of 24.73 ± 0.53 mmol g (dry cell weight)⁻¹ h⁻¹ with an apparent growth yield (Y) of 0.40 ± 0.01 g (dry cell weight) mol⁻¹ NH₃ . These conditions likely influence ribosomal protein expression.
Biofilm vs. Planktonic Growth:
N. europaea forms biofilms differently in single-species cultures versus dual-species cultures with P. aeruginosa . In single-species biofilms, N. europaea formed thin, dispersed layers, while in dual-species biofilms, it developed much greater biovolume (2.78 μm³/μm² at day 3) . These growth modes may differentially affect ribosomal protein expression.
Understanding these native expression patterns can inform recombinant production strategies by:
Selecting growth conditions that naturally upregulate ribosomal proteins
Designing expression constructs with promoters responsive to specific environmental cues
Engineering host strains to mimic favorable conditions for ribosomal protein expression
Verifying the structural integrity and functionality of purified recombinant N. europaea rplA requires multiple analytical approaches:
Structural Integrity Assessment:
Circular Dichroism (CD) spectroscopy to analyze secondary structure composition
Differential Scanning Calorimetry (DSC) to assess thermal stability
Size-Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) to determine oligomeric state and homogeneity
Limited proteolysis to probe folding and domain structure
Functional Characterization:
In vitro binding assays with 23S rRNA fragments
Ribosome reconstitution assays to test incorporation into 50S subunits
Poly(U)-directed poly(Phe) synthesis to assess contribution to translation
Sucrose gradient ultracentrifugation to assess incorporation into ribosomal subunits
Molecular Dynamics Simulations:
Computational analysis of protein stability
Prediction of RNA-binding interfaces
Simulation of interactions with other ribosomal components
Each of these methods contributes complementary information about the protein's structure and function, allowing for comprehensive characterization of the recombinant product.
Activity-based protein profiling (ABPP) methodologies, similar to those used for studying ammonia monooxygenase in N. europaea , can be adapted to investigate rplA interactions:
Probe Design for rplA Interactions:
Synthesis of RNA oligonucleotides corresponding to the rplA binding site on 23S rRNA
Incorporation of reactive groups (photoactivatable crosslinkers) and reporter tags (biotin, fluorophores)
Design of protein-based probes representing interaction partners within the ribosome
Crosslinking Methodology:
In vitro reconstitution of ribosomal subunits with recombinant rplA
UV-induced crosslinking of interacting components
Chemical crosslinking using bifunctional reagents
Interaction Analysis:
Mass spectrometry identification of crosslinked peptides
Competition assays with unlabeled rplA to validate specificity
Mutational analysis of interaction interfaces
Visualization Techniques:
Fluorescence microscopy to track labeled rplA localization
In-gel detection of crosslinked complexes
Structural analysis of crosslinked complexes by cryo-EM
This approach would provide detailed insights into the dynamic interactions of rplA within the ribosomal complex, potentially revealing novel aspects of ribosome assembly and function in N. europaea.
The impact of rplA mutation on N. europaea metabolism can be studied using a combination of genomic, proteomic, and biochemical approaches:
Genetic Modification Strategies:
Creation of rplA knockout or knockdown strains
Point mutations in conserved residues
Complementation with recombinant wild-type or mutant rplA
Phenotypic Characterization:
Growth rate analysis under various conditions
Ammonia oxidation rates measured by NO₂⁻ production
Oxygen consumption rates
Cell morphology and ultrastructure analysis
Metabolic Impact Assessment:
Transcriptomic analysis to identify differentially expressed genes
Proteomic analysis focusing on ammonia oxidation enzymes (AMO, HAO)
Metabolomic profiling
Recombinant Protein Applications:
In vitro translation assays comparing wild-type and mutant rplA
Structure-function studies of mutant rplA variants
Protein-protein interaction studies with other ribosomal components
Based on studies of N. europaea's metabolic pathways, key processes to monitor would include:
Hydroxylamine oxidation by hydroxylamine dehydrogenase (HAO)
Expression of nitrite reductase (NirK) and nitric oxide reductase (NorB)
Carbon fixation pathways
Recombinant N. europaea rplA can be engineered for novel synthetic biology applications, particularly in environmental monitoring:
Biosensor Development:
Creation of fusion proteins between rplA and reporter systems (GFP, luciferase)
Development of riboswitch-based sensors using rplA binding domains
Design of cell-free translation systems incorporating modified rplA
Environmental Monitoring Applications:
Detection of ribosome-targeting antibiotics in water samples
Assessment of protein synthesis inhibitors in environmental samples
Monitoring of factors affecting ammonia oxidation
Methodological Approaches:
Integration with Existing Systems:
Incorporation into microbial fuel cells for power generation coupled with sensing
Development of microfluidic devices for continuous monitoring
Creation of whole-cell biosensors using genetic circuits involving rplA
These applications build on existing knowledge of N. europaea's biology, including its ammonia oxidation pathway and response to environmental stressors, while leveraging the fundamental role of rplA in protein synthesis to create novel detection systems.